ReviewBiomaterials translational2026
Cellular mechanisms of osteoporosis: A comprehensive perspective on ferroptosis, cuproptosis and lipid metabolism abnormalities.
Review in Biomaterials translational, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis is a prevalent skeletal disorder characterised by reduced bone mineral density and compromised bone microarchitecture, leading to increased bone fragility and increased risk of fracture. Recent studies have implicated ferroptosis, cuproptosis, and dysregulated lipid metabolism as pivotal factors in the pathogenesis of osteoporosis. Ferroptosis is an iron-dependent form of cell death that disrupts the balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption by promoting lipid peroxidation and inducing cellular injury. Cuproptosis, associated with disruptions in copper homeostasis, influences bone cell integrity through oxidative stress and inflammatory responses, thereby impacting bone density. Aberrant lipid metabolism may exacerbate osteoporosis by disrupting bone-fat homeostasis, oxidative stress, and inflammatory responses. This review synthesizes the interplay between cuproptosis, ferroptosis, and lipid metabolism, elucidates the cellular mechanisms underlying osteoporosis, and accordingly provides novel therapeutic targets and intervention strategies, potentially enhancing osteoporosis prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.